| Feb 17, 2026 |
Feb 18, 2026 |
Chaubey Alka
|
CHIEF MEDICAL OFFICER |
Sell |
47.5
|
-18
|
-2.72%
|
✗
|
$19.8 |
| Feb 17, 2026 |
Feb 18, 2026 |
Adamchak Mark
|
Principal Accounting Officer |
Sell |
47.5
|
-3
|
-1.14%
|
✗
|
$3.3 |
| Feb 17, 2026 |
Feb 18, 2026 |
Dixon Jonathan V.
|
GENERAL COUNSEL |
Sell |
47.5
|
-6
|
-2.23%
|
✗
|
$6.6 |
| Feb 17, 2026 |
Feb 18, 2026 |
OLDAKOWSKI MARK
|
COO |
Sell |
47.5
|
-20
|
-2.19%
|
✗
|
$22 |
| Feb 17, 2026 |
Feb 18, 2026 |
Holmlin R. Erik
|
CEO |
Sell |
47.5
|
-51
|
-2.99%
|
✗
|
$56.1 |
| Feb 2, 2026 |
Feb 4, 2026 |
Adamchak Mark
|
Principal Accounting Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 2, 2026 |
Feb 4, 2026 |
Chaubey Alka
|
CHIEF MEDICAL OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 2, 2026 |
Feb 4, 2026 |
OLDAKOWSKI MARK
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 2, 2026 |
Feb 4, 2026 |
Dixon Jonathan V.
|
GENERAL COUNSEL |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 2, 2026 |
Feb 4, 2026 |
Holmlin R. Erik
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 11, 2025 |
Sep 12, 2025 |
OLDAKOWSKI MARK
|
COO |
Sell |
47.5
|
-59
|
-6.06%
|
✗
|
$239.5 |
| Sep 11, 2025 |
Sep 12, 2025 |
OLDAKOWSKI MARK
|
COO |
Sell |
47.5
|
-59
|
-6.06%
|
✗
|
$239.5 |
| Sep 11, 2025 |
Sep 12, 2025 |
Chaubey Alka
|
Chief Medical Officer |
Sell |
47.5
|
-51
|
-7.15%
|
✗
|
$207.1 |
| Jun 11, 2025 |
Jun 12, 2025 |
TWOMEY CHRISTOPHER J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 11, 2025 |
Jun 12, 2025 |
Vuori Kristiina MD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 11, 2025 |
Jun 12, 2025 |
Linney Yvonne
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 11, 2025 |
Jun 12, 2025 |
Luderer Albert
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 11, 2025 |
Jun 12, 2025 |
BARKER DAVID L
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 11, 2025 |
Jun 12, 2025 |
Mamuszka Hannah
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 11, 2025 |
Jun 12, 2025 |
Rajkovic Aleksandar
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 3, 2025 |
Jun 3, 2025 |
OLDAKOWSKI MARK
|
COO |
Sell |
47.5
|
-27
|
-2.70%
|
✗
|
$99.6 |
| Jun 3, 2025 |
Jun 3, 2025 |
Adamchak Mark
|
Principal Accounting Officer |
Sell |
47.5
|
-7
|
-2.59%
|
✗
|
$25.8 |
| Jun 3, 2025 |
Jun 3, 2025 |
Chaubey Alka
|
Chief Medical Officer |
Sell |
47.5
|
-24
|
-3.26%
|
✗
|
$88.6 |
| Jun 3, 2025 |
Jun 3, 2025 |
Holmlin R. Erik
|
CEO |
Sell |
47.5
|
-75
|
-4.19%
|
✗
|
$276.8 |
| Jun 3, 2025 |
Jun 3, 2025 |
Dixon Jonathan V.
|
General Counsel |
Sell |
47.5
|
-25
|
-8.50%
|
✗
|
$92.3 |
| Mar 14, 2025 |
Mar 18, 2025 |
Dixon Jonathan V.
|
General Counsel |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 14, 2025 |
Mar 18, 2025 |
Adamchak Mark
|
Principal Accounting Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 14, 2025 |
Mar 18, 2025 |
Holmlin R. Erik
|
CEO |
Sell |
47.5
|
-198
|
-9.95%
|
✗
|
$687.1 |
| Mar 14, 2025 |
Mar 18, 2025 |
OLDAKOWSKI MARK
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 14, 2025 |
Mar 18, 2025 |
Chaubey Alka
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 15, 2025 |
Feb 19, 2025 |
OLDAKOWSKI MARK
|
COO |
Sell |
47.5
|
-20
|
-1.96%
|
✗
|
$114.6 |
| Feb 15, 2025 |
Feb 19, 2025 |
Dixon Jonathan V.
|
General Counsel |
Sell |
47.5
|
-6
|
-2.00%
|
✗
|
$34.4 |
| Feb 15, 2025 |
Feb 19, 2025 |
Holmlin R. Erik
|
CEO |
Sell |
47.5
|
-51
|
-2.50%
|
✗
|
$292.2 |
| Feb 15, 2025 |
Feb 19, 2025 |
Chaubey Alka
|
Chief Medical Officer |
Sell |
47.5
|
-18
|
-2.38%
|
✗
|
$103.1 |
| Feb 15, 2025 |
Feb 19, 2025 |
Adamchak Mark
|
Principal Accounting Officer |
Sell |
47.5
|
-4
|
-1.46%
|
✗
|
$22.9 |
| Oct 1, 2024 |
Oct 2, 2024 |
Adamchak Mark
|
Principal Accounting Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Sep 30, 2024 |
Adamchak Mark
|
Principal Accounting Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 11, 2024 |
Sep 13, 2024 |
OLDAKOWSKI MARK
|
COO |
Sell |
47.5
|
-3,568
|
-5.50%
|
✗
|
$1.7K |
| Sep 11, 2024 |
Sep 13, 2024 |
Chaubey Alka
|
Chief Medical Officer |
Sell |
47.5
|
-3,075
|
-6.35%
|
✗
|
$1.5K |
| Jun 18, 2024 |
Jun 20, 2024 |
Rajkovic Aleksandar
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2024 |
Jun 20, 2024 |
Luderer Albert
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2024 |
Jun 20, 2024 |
Vuori Kristiina MD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2024 |
Jun 20, 2024 |
BARKER DAVID L
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2024 |
Jun 20, 2024 |
Wong Vincent Jung-Fai
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2024 |
Jun 20, 2024 |
Mamuszka Hannah
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2024 |
Jun 20, 2024 |
TWOMEY CHRISTOPHER J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2024 |
Jun 20, 2024 |
Linney Yvonne
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 3, 2024 |
Jun 5, 2024 |
OLDAKOWSKI MARK
|
COO |
Neutral |
90.0
|
+16,000
|
32.86%
|
✗
|
- |
| Jun 3, 2024 |
Jun 5, 2024 |
Kama Gulsen
|
CFO |
Neutral |
90.0
|
+16,000
|
100.00%
|
✗
|
- |
| Jun 3, 2024 |
Jun 5, 2024 |
Holmlin R. Erik
|
CEO |
Neutral |
90.0
|
+44,000
|
56.18%
|
✗
|
- |
| Jun 3, 2024 |
Jun 5, 2024 |
Dixon Jonathan V.
|
GENERAL COUNSEL |
Neutral |
90.0
|
+14,500
|
411.35%
|
✗
|
- |
| Jun 3, 2024 |
Jun 5, 2024 |
Chaubey Alka
|
CHIEF MEDICAL OFFICER |
Neutral |
90.0
|
+16,000
|
49.62%
|
✗
|
- |
| Feb 15, 2024 |
Mar 5, 2024 |
Chaubey Alka
|
CHIEF MEDICAL OFFICER |
Sell |
47.5
|
-1,081
|
-3.32%
|
✗
|
$1.4K |
| Feb 15, 2024 |
Mar 5, 2024 |
OLDAKOWSKI MARK
|
COO |
Sell |
47.5
|
-1,229
|
-2.46%
|
✗
|
$1.6K |
| Feb 15, 2024 |
Mar 5, 2024 |
Holmlin R. Erik
|
CEO |
Sell |
47.5
|
-3,073
|
-3.78%
|
✗
|
$3.9K |
| Feb 15, 2024 |
Mar 5, 2024 |
Dixon Jonathan V.
|
GENERAL COUNSEL |
Sell |
47.5
|
-402
|
-10.24%
|
✗
|
$510.5 |
| Sep 18, 2023 |
Sep 20, 2023 |
OLDAKOWSKI MARK
|
COO |
Neutral |
85.0
|
+20,000
|
6.71%
|
✗
|
- |
| Sep 18, 2023 |
Sep 20, 2023 |
Chaubey Alka
|
Chief Medical Officer |
Neutral |
90.0
|
+20,000
|
16.03%
|
✗
|
- |
| Sep 18, 2023 |
Sep 20, 2023 |
Kama Gulsen
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Sep 20, 2023 |
Kama Gulsen
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 14, 2023 |
Jun 16, 2023 |
Mamuszka Hannah
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 14, 2023 |
Jun 16, 2023 |
Rajkovic Aleksandar
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 14, 2023 |
Jun 16, 2023 |
Luderer Albert
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 14, 2023 |
Jun 16, 2023 |
Linney Yvonne
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 14, 2023 |
Jun 16, 2023 |
Wong Vincent Jung-Fai
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 14, 2023 |
Jun 16, 2023 |
Vuori Kristiina MD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 14, 2023 |
Jun 16, 2023 |
TWOMEY CHRISTOPHER J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 14, 2023 |
Jun 16, 2023 |
BARKER DAVID L
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 13, 2023 |
Jun 14, 2023 |
Mamuszka Hannah
|
Director |
Buy |
91.3
|
+65,789
|
100.00%
|
✗
|
$50K |
| May 16, 2023 |
May 16, 2023 |
Holmlin R. Erik
|
CEO |
Buy |
77.5
|
+15,000
|
1.88%
|
✗
|
$9.6K |
| May 12, 2023 |
May 16, 2023 |
Stewart Christopher P.
|
CFO |
Buy |
91.3
|
+50,000
|
21.61%
|
✗
|
$33.4K |
| May 12, 2023 |
May 16, 2023 |
OLDAKOWSKI MARK
|
COO |
Sell |
46.3
|
-41,496
|
-12.23%
|
✗
|
$27.4K |
| May 12, 2023 |
May 16, 2023 |
Holmlin R. Erik
|
CEO |
Sell |
46.3
|
-50,141
|
-5.92%
|
✗
|
$33.1K |
|
Mar 6, 2023 |
Dixon Jonathan V.
|
General Counsel |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 15, 2023 |
Feb 17, 2023 |
Holmlin R. Erik
|
CEO |
Neutral |
90.0
|
+300,000
|
54.88%
|
✗
|
- |
| Feb 15, 2023 |
Feb 17, 2023 |
OLDAKOWSKI MARK
|
COO |
Neutral |
90.0
|
+120,000
|
54.71%
|
✗
|
- |
| Feb 15, 2023 |
Feb 17, 2023 |
Chaubey Alka
|
Chief Medical Officer |
Neutral |
90.0
|
+120,000
|
2503.13%
|
✗
|
- |
| Feb 15, 2023 |
Feb 17, 2023 |
Stewart Christopher P.
|
CFO |
Neutral |
90.0
|
+105,000
|
83.09%
|
✗
|
- |
| Aug 15, 2022 |
Aug 17, 2022 |
Linney Yvonne
|
Director |
Sell |
22.5
|
-20,000
|
-100.00%
|
✗
|
$72.4K |
| Jun 30, 2020 |
Jul 18, 2022 |
TWOMEY CHRISTOPHER J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 30, 2020 |
Jul 18, 2022 |
Luderer Albert
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 30, 2020 |
Jul 18, 2022 |
Linney Yvonne
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 30, 2020 |
Jul 18, 2022 |
Vuori Kristiina MD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 30, 2020 |
Jul 18, 2022 |
Mamuszka Hannah
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 7, 2022 |
Jul 11, 2022 |
BARKER DAVID L
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 9, 2022 |
Jun 13, 2022 |
Rajkovic Aleksandar
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 9, 2022 |
Jun 13, 2022 |
Mamuszka Hannah
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 9, 2022 |
Jun 13, 2022 |
Luderer Albert
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 9, 2022 |
Jun 13, 2022 |
Linney Yvonne
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 9, 2022 |
Jun 13, 2022 |
BARKER DAVID L
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 9, 2022 |
Jun 13, 2022 |
Wong Vincent Jung-Fai
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 9, 2022 |
Jun 13, 2022 |
Vuori Kristiina MD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 9, 2022 |
Jun 13, 2022 |
TWOMEY CHRISTOPHER J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 16, 2022 |
May 18, 2022 |
BARKER DAVID L
|
Director |
Buy |
91.3
|
+10,000
|
256.81%
|
✗
|
$16K |
| May 13, 2022 |
May 16, 2022 |
Stewart Christopher P.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 12, 2022 |
May 16, 2022 |
OLDAKOWSKI MARK
|
COO |
Sell |
42.5
|
-41,496
|
-16.07%
|
✗
|
$58.5K |
| May 12, 2022 |
May 16, 2022 |
Holmlin R. Erik
|
CEO |
Sell |
42.5
|
-50,141
|
-8.45%
|
✗
|
$70.7K |
| Feb 17, 2022 |
Feb 22, 2022 |
Rajkovic Aleksandar
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 22, 2022 |
Rajkovic Aleksandar
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 15, 2022 |
Feb 15, 2022 |
Shams Soheil
|
Chief Informatics Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |